PBOV1 promotes prostate cancer proliferation by promoting G1/S transition

Area of Science:

• Oncology
• Molecular Biology

Background:

• Prostate cancer (PC) is a leading cause of cancer death in men, necessitating the identification of novel therapeutic targets.
• Prostate and breast cancer overexpressed 1 (PBOV1) is overexpressed in multiple cancers, including prostate cancer serum, but its specific role in PC remains uninvestigated.

Purpose of the Study:

• To elucidate the function of PBOV1 in prostate cancer progression.
• To determine the molecular mechanisms by which PBOV1 influences PC cell behavior.

Main Methods:

• Quantitative analysis of PBOV1 expression in PC cells.
• In vitro assays assessing cell proliferation, colony formation, and cell cycle progression upon PBOV1 manipulation (overexpression and knockdown).
• Western blot analysis to evaluate the impact of PBOV1 on cell cycle regulatory proteins (p21, p27, Rb, cyclin D1).

Main Results:

• PBOV1 is significantly overexpressed in PC cells.
• PBOV1 overexpression enhanced PC cell proliferation, colony formation, and tumorigenicity in vitro.
• Knockdown of PBOV1 reversed these pro-tumorigenic effects.
• PBOV1 overexpression led to decreased levels of cell cycle inhibitors p21 and p27, increased Rb phosphorylation, and elevated cyclin D1 expression, indicating promotion of G1/S phase transition.

Conclusions:

• PBOV1 acts as a positive regulator of prostate cancer cell proliferation.
• PBOV1 promotes PC progression by facilitating the G1/S phase transition via modulation of key cell cycle regulators.
• PBOV1 represents a potential therapeutic target for prostate cancer treatment.